These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22450396)

  • 21. The clinical significance of persistently normal ALT in chronic hepatitis B infection.
    Lai M; Hyatt BJ; Nasser I; Curry M; Afdhal NH
    J Hepatol; 2007 Dec; 47(6):760-7. PubMed ID: 17928090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase.
    Montazeri G; Rahban M; Mohamadnejad M; Zamani F; Hooshyar A; Fazlolahi A; Abedian S; Ghoujeghi F; Estakhri A; Montazeri F; Razjoyan H; Mamarabadi M; Alimohamadi M; Tavangar SM; Malekzadeh R
    Arch Iran Med; 2010 May; 13(3):193-202. PubMed ID: 20433223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
    Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hepatitis B viraemia levels in patients with HBeAg-negative chronic hepatitis B virus infection.
    Atay AE; Seven G; Yalcin K; Pasa S; Degertekin H
    J Int Med Res; 2012; 40(5):1891-6. PubMed ID: 23206472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viral factors influencing histological changes of HBeAg-negative chronic hepatitis B patients with persistently normal serum ALT levels].
    Yang YH; Xie Q; Wang H; Zhou HJ; Gui HL; Cai W; Guo SM; Yu H; Guo Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):434-9. PubMed ID: 19567022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
    Gao Y; Wang M; Liu X
    Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection.
    Barut S; Gemici Ü; Güneş F; Demir O; Duygu F
    J Med Virol; 2017 Nov; 89(11):1952-1957. PubMed ID: 28618019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
    Duan M; Chi X; Xiao H; Liu X; Zhuang H
    Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers].
    Olut AI; Ozünlü H; Bozdağ H; Ozkalay N
    Mikrobiyol Bul; 2007 Jul; 41(3):429-33. PubMed ID: 17933254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of hepatitis B e antigen-negative chronic hepatitis B.
    Amarapurkar DN; Baijal R; Kulshrestha PP; Agal S; Chakraborty MR; Pramanik SS
    Indian J Gastroenterol; 2002; 21(3):99-101. PubMed ID: 12118935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase.
    Gui HL; Wang H; Yang YH; Wu YW; Zhou HJ; Guo SM; Lin LY; Wang L; Cai W; Chen R; Guo Q; Zhou XQ; Bao SS; Xie Q
    J Viral Hepat; 2010 Mar; 17 Suppl 1():44-50. PubMed ID: 20586933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
    Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
    Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognosis and management of inactive HBV carriers.
    Invernizzi F; Viganò M; Grossi G; Lampertico P
    Liver Int; 2016 Jan; 36 Suppl 1():100-4. PubMed ID: 26725905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.